+ Watch PDLI
on My Watchlist
A biopharmaceutical company focused on discovering, developing and commercializing innovative therapies for severe or life-threatening illnesses.
on 8-18-12 Momentum21 picked PDLI
Booyah! MOMO siezes the momentum with a .15 div on 9/06./12 lowering the start price to $7.23.
PDL Bio announces 2nd stage dividend results-.14 divi lowering the start price to $7.09.
3rd stage dividend results are in, .15 divi lowering the start price to $6.94.
4th stage dividend results are in-$6.82(awaiting fda approval for inevitable run up in price)
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ratings and Key Statistics provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions